Salute e Benessere

Infinium Global Research Reveals Explosive Growth in 3D Printing Medical Device…

The 3D printing medical device market is experiencing remarkable growth, driven by a multitude of factors, including advancements in 3D printing technology and the ease of creating customized medical products. This growth is evident in the production of 3D-printed prosthetics, implants, dental restorations, surgical instruments, and tissues. Over 20 types of implants, including cranial, hip, knee, and spinal implants, have been FDA-approved, and manufactured using various 3D printing…
PR Newswire
16/10/2023

Clinical Decision Support Systems Market Projected to Reach USD 10.97 Billion by…

The growth of the CDSS market is underpinned by remarkable advancements in Artificial Intelligence (AI) and Machine Learning (ML). These transformative technologies enhance the capabilities of CDSS, allowing for the analysis of extensive healthcare data, which, in turn, provides more personalized and predictive recommendations. Moreover, the integration of CDSS with Electronic Health Record (EHR) systems has become increasingly seamless, allowing immediate access to patient data and clinical…
PR Newswire
16/10/2023

Ukrainian medical professionals receive comprehensive training in the field of…

"Össur has been diligently supporting Ukrainian medical professionals and amputees in need since the beginning of the war in February 2022 and we are committed to contributing to the positive development of prosthetic care in the country," said Sveinn Sölvason, President and CEO of Össur. According to Sölvason, the number of amputees is increasing daily as a consequence of the ongoing war, and the need for trained specialists is also on the rise. "Joining forces with Protez Hub on…
PR Newswire
16/10/2023

Virbac : Declaration of the number of shares and voting rights 0/2023

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20238 458 000Gross total of...
Nasdaq GlobeNewswire
16/10/2023

Telehealth Market to Reach $784.3 Billion, Globally, by 2032 at 25.2% CAGR…

Telehealth refers to the sector of the healthcare industry that uses telecommunications technology to deliver remote healthcare services such as medical consultation, diagnosis, monitoring, treatment, and more. Telehealth allows healthcare professionals to communicate with patients through video calls, telephone calls, messaging, and other forms of digital communication without the need for an in-person visit. Telehealth encompasses a broad range of applications such as tele prescribing, remote…
PR Newswire
16/10/2023

Successful Launch of JVM's Next-Generation Automated Drug Dispensing System via…

Based on this contract, JVM will be able to expand its European business, which had been focused on entry-level models, to 'large-scale high-end models'. The company explained that since most overseas factory-type dispensing pharmacies repackage prescription drugs and deliver them all across the country, the market is expected to implement more MENITH units, which can significantly improve pharmacy workflow. Based on this contract, JVM will be able to expand its European business, which had...
PR Newswire
16/10/2023

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress…

Program updates include new data for investigational CAR-T and ex-vivo T cell therapies, a novel ADC, a FixVac off-the-shelf mRNA cancer vaccine, and a bi-specific antibody New data from BioNTech's investigational autologous CAR-T therapy BNT211 demonstrate the potential of the Company's innovative approach of combining an autologous CAR-T cell therapy targeting Claudin-6 (“CLDN6”) with a CLDN6-encoding CAR-T cell amplifying mRNA vaccine (“CARVac”)First-in-human data from Phase 1/2...
Nasdaq GlobeNewswire
16/10/2023

SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline

Under the terms of the agreement, Synaffix will be eligible to receive up to $740 million in payments spanning signature, target nomination and milestone payments plus additional royalties on commercial sales. SOTIO will be responsible for the research, development, and commercialization of the ADCs. Synaffix will be responsible for the manufacturing of components that are specifically related to its proprietary technologies. Under the terms of the agreement, Synaffix will be eligible to...
PR Newswire
16/10/2023

Update Regarding Pfizer's Statement on COMIRNATY-Related Write-Offs

MAINZ, Germany, October 16, 2023 (GLOBE NEWSWIRE)-- On October 13, 2023, Pfizer Inc. (NYSE: PFE, “Pfizer”), a collaboration partner of BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), announced a non-cash charge for inventory write-offs and other charges related to COMIRNATY of $0.9 billion. The Company has been informed by Pfizer that the majority of the write-offs relate to raw materials, mainly formulation-related lipids, purchased during the pandemic, as well as COVID-19...
Nasdaq GlobeNewswire
16/10/2023

Guelph General Hospital in Canada goes live with cloud-based enterprise imaging…

Gavin Webb, Vice President, Finance & Chief Information Officer at Guelph General Hospital shares why the organization decided to head to the cloud: "We required a single system that could help solve our infrastructure limitations and provide fast access to medical images and data so our staff can make informed decisions faster. Sectra supports the technology and operations of the platform so our team can focus on delivering high-quality patient care in the region." Gavin Webb…
PR Newswire
16/10/2023

New data from LEQEMBI® (lecanemab-irmb) phase 3 Clarity AD study and…

Late-Breaking Symposium 4 – Lecanemab for early Alzheimer's Disease: Long-Term Outcomes, Predictive Biomarkers, and Novel Subcutaneous Administration Late-Breaking Symposium 4 – Lecanemab for early Alzheimer's Disease: Long-Term Outcomes, Predictive Biomarkers, and Novel Subcutaneous Administration Oral Presentations Poster Presentations This release discusses investigational uses of an agent in development and is not intended to convey conclusions about efficacy or safety...
PR Newswire
16/10/2023

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial…

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointment of Virginie Boucinha as its Chief Financial Officer, effective November 6, 2023. An experienced financial and operations executive, Virginie will report directly to Daniel Tassé, Chief Executive Officer, and serve as a member of the Executive...
Nasdaq GlobeNewswire
16/10/2023

Casino Group: Disposal of Casino's stake in Éxito Group

Disposal of Casino's stake in Éxito Group Paris, 16 October 2023Casino Group announces that its Board of Directors approved on Friday, 13 October 2023 the execution of a pre-agreement (“Pre-Agreement”) with Grupo Calleja, which owns the leading grocery retailer group in El Salvador and operates under the Super Selectos brand (the “Buyer”) for the sale of Casino's total equity interest in Almacenes Éxito S.A. (“Éxito Group”), corresponding to 34.05 % of Éxito Group's capital stock, in...
Nasdaq GlobeNewswire
16/10/2023

Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be…

The poster will be available on BerGenBio's website shortly following presentation. The poster will be available on BerGenBio's website shortly following presentation. In addition, Dr. Oddbjorn Straume, M.D., Ph.D., Assistant Professor, Clinical Science at the Haukeland University Hospital inBergen, Norwaywill make an oral presentation summarizing the results of the Investigator Led Study LBA52 with bemcentinib in addition to pembrolizumab or dabrafenib/trametinib in 1L and 2L...
PR Newswire
16/10/2023

Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month…

PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer PortfolioMechelen, Belgium, 16 October 2023– Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company, announces the launch of the new Breast Cancer Portfolio during the Breast Cancer Awareness month: the Idylla™ PIK3CA-AKT1 Mutation Assay and, in collaboration with APIS Assay Technologies ('APIS'), the APIS Breast Cancer Subtyping...
Nasdaq GlobeNewswire
16/10/2023

UEG Week 2023 : Babies with a low birthweight four times more likely to develop…

Researchers conducted a population-based case-control study of all people aged 25 years and younger, who had been diagnosed with MASLD between January 1992 and April 2017, totalling 165 cases. Each individual with MASLD was matched with up to five controls from the general population based on age, sex, calendar year and county of residence. Researchers conducted a population-based case-control study of all people aged 25 years and younger, who had been diagnosed with MASLD betweenJanuary 1992...
PR Newswire
16/10/2023

HEALTHSCOPE : AI ENABLES PATIENT EMOTIONS TO BE ANALYSED IMPROVING HOSPITAL…

Anita Hodge National Manager Reported Experience and Outcomes for Healthscope says going beyond numbers to "understand patient emotions and each individual story" now plays a key role to better understanding how to improve patient experience. Anita Hodge National Manager Reported Experience and Outcomes for Healthscope says going beyond numbers to "understand patient emotions and each individual story" now plays a key role to better understanding how to improve patient…
PR Newswire
15/10/2023

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA…

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody ®sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa (HS)Maintenance treatment with sonelokimab dosed every 4 weeks (Q4W), demonstrated that 57% of patients achieved HiSCR75 at week 24, increasing the landmark week 12 responses (primary endpoint) by over 10 ppt (percentage points)The depth of responses continued...
Nasdaq GlobeNewswire
15/10/2023

World Health Summit kicks off in Berlin

The opening ceremony takes place tonight at 6:00 PM CEST. Speakers on stage will include German Minister of Health Karl Lauterbach, Ayoade Alakija, medical doctor from Nigeria and WHO Special Envoy, Youth Envoy to the President of the UN 27th Climate Change Conference (COP27)Omnia El Omrani, WHO Director-General Tedros Adhanom Ghebreyesus, who will join live digitally, as well as Christina Chilimba, founder of a youth organization in Malawi. Video messages include the Prime Minister of Barbados…
PR Newswire
15/10/2023

Groupe Casino: Update on accession to the lock-up agreement relating to the…

Update on accession to the lock-up agreement relating to the financial restructuring of the GroupExtension of the accession period to the lock-up agreement relating to the financial restructuring of the Group Paris, 13 October 2023Further to its press releases of 5 October 2023 and 11 October 2023, Casino Group announces that by 13 October 2023, the following creditors have acceded to the lock-up agreement relating to its financial restructuring entered into on 5 October 2023 (the "...
Nasdaq GlobeNewswire
13/10/2023

World Thrombosis Day encourages public to "Move Against Thrombosis" as it…

DUBAI, UAE, Oct. 13, 2023 /PRNewswire/ -- Today is World Thrombosis Day, a global effort established by the International Society on Thrombosis and Haemostasis (ISTH) to spread awareness of the signs, symptoms and risk factors of thrombosis, commonly known as blood clots. With one in four people dying worldwide from conditions related to blood clots, thrombosis is the leading cause of preventable hospital deaths across the globe. DUBAI, UAE,Oct. 13, 2023/PRNewswire/ -- Today isWorld...
PR Newswire
13/10/2023

Revenue growth as of September 2023 by 40%

Press release Ecully, October 13, 2023 – 6 p.m. 9-month revenue up 40% at €7.5 millionIn thousands of eurosUnaudited data 20232022% change Q1 revenue2,399 1,342 +79%Q2 revenue3,034 1,770 +71%Q3 revenue2,077 2,249 -8% 9M revenue* 7,509 5,361 +40%* 9M 2022 revenue included the share of revenue derived from Spine Innovations following its consolidation on July 21, 2022, i.e. €0.9 million. Spineway...
Nasdaq GlobeNewswire
13/10/2023

Ventilators Market Worth $5.7 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337 Browse in-depth TOC on "Ventilators Market"259 - Tables57 - Figures 290 - Pages Ventilators Market Scope: Based on mobility, intensive care ventilators segment holds the largest share ventilators market In 2022, the intensive care ventilators segment holds the...
PR Newswire
13/10/2023

PINK CHARITY SKI - SKISET and EDL SKI launch campaign for the League Against…

Limited edition of 180 pairs for France and 20 pairs for Switzerland. Limited edition of 180 pairs forFranceand 20 pairs forSwitzerland. This one off ski has been designed in pink to reflect the colours of the breast cancer awareness campaign, but has the same build quality as EDL Cobalt, one of the flagship models of the EDL SKI collection. It's a dynamic, lively, playful ski, intended purely for having fun. Did you know ? Skiset was also a partner of Odyssea La Plagne...
PR Newswire
13/10/2023
Altri  Comunicati